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High-fatdiets (HFDs) lead toobesityand inflammation
in the central nervous system (CNS). Estrogens and
estrogen receptor a (ERa) protect premenopausal
females from the metabolic complications of inflam-
mationandobesity-relateddisease.Here,wedemon-
strate that hypothalamic PGC-1a regulates ERa and
inflammation in vivo. HFD significantly increased pal-
mitic acid (PA) and sphingolipids in the CNS of male
mice when compared to female mice. PA, in vitro,
and HFD, in vivo, reduced PGC-1a and ERa in hypo-
thalamic neurons and astrocytes of male mice and
promoted inflammation. PGC-1a depletion with ERa
overexpression significantly inhibited PA-induced
inflammation, confirming that ERa is a critical deter-
minant of the anti-inflammatory response. Physio-
logic relevance of ERa-regulated inflammation was
demonstrated by reduced myocardial function in
male, but not female, mice following chronic HFD
exposure. Our findings show that HFD/PA reduces
PGC-1aandERa, promoting inflammationanddecre-
ments in myocardial function in a sex-specific way.INTRODUCTION
In the last 50 years, obesity has become a global epidemic. The
World Health Organization estimates that more than half a billion
adults worldwide are obese (Gregor and Hotamisligil, 2011).
Obesity is associated with chronic, low-grade inflammation in
adipose tissuesand in the central nervous system (CNS) (Hotami-
sligil, 2006; Thaler et al., 2012). CNS inflammation, in turn, leads
to insulin and leptin resistance and facilitates the onset of cardio-
vascular disease (Purkayastha et al., 2011; Thaler et al., 2012;
Zhang et al., 2008); however, the mechanisms underlying CNS
inflammation and accompanying comorbidities remain unclear.CThe saturated long-chain fatty acid palmitic acid (PA) induces
inflammation in the hypothalamus, and the plasma concentra-
tion of PA is significantly increased in obesity (Opie and Walfish,
1963; Reaven et al., 1988). Furthermore, PA crosses the blood-
brain barrier (Dhopeshwarkar and Mead, 1973; Smith and Na-
gura, 2001), and high-fat diets (HFDs) promote CNS uptake of
PA (Karmi et al., 2010; Wang et al., 1994). Intracerebroventricular
infusion of PA activates proinflammatory responses in the hypo-
thalamus and promotes insulin resistance (Posey et al., 2009).
Thus, PA-induced hypothalamic inflammation could play a crit-
ical role in the development of obesity-related diseases such
as cardiovascular disease.
Although obesity affects both males and females, there is a
sexual dimorphism in the development of metabolic complica-
tions associated with obesity (Shi et al., 2009; Sugiyama and
Agellon, 2012). Premenopausal women are protected from
the adverse effects of obesity; however, the prevalence of
metabolic disorders increases significantly after menopause
(Ford, 2005). Interestingly, 17b-estradiol (E2) and its receptor,
estrogen receptor a (ESR1/ERa), protect against obesity-related
diseases (Musatov et al., 2007; Xu et al., 2011). Abnormal
adiposity and glucose intolerance have been associated with
polymorphisms and point mutations of the human Era gene
(Okura et al., 2003; Smith et al., 1994), and mice lacking ERa
(ERKO) have increased adiposity and impaired glucose toler-
ance (Heine et al., 2000).
The peroxisome proliferator-activated receptor gamma, coac-
tivator 1 a (PGC-1a) is a transcriptional coactivator involved
in multiple metabolic pathways (Lin et al., 2005). PGC-1a is
reduced in adipose tissue in genetically obese mice (Lepob/
Lepob) as well as following HFD exposure (Crunkhorn et al.,
2007). However, its role in the hypothalamus in the response to
an HFD has not been characterized. Two studies have demon-
strated that PGC-1a transcriptionally regulates ERa in vitro
(Bourdoncle et al., 2005; Tcherepanova et al., 2000); however,
it is unknownwhether this regulation occurs in the hypothalamus
in vivo.
In the present study, we evaluate the sexually dimorphic
response to chronic HFD exposure. We demonstrate PA andell Reports 9, 633–645, October 23, 2014 ª2014 The Authors 633
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sphingolipids are increased in the CNS of male when compared
to female mice following consumption of an HFD. We show
that chronic HFD exposure promotes hypothalamic inflamma-
tion and reduces ERa in male, but not female, mice. Further,
we demonstrate that hypothalamic inflammation depresses
myocardial function in male, but not female, mice. Treatment
of neuronal and astrocyte cell cultures with PA, to mimic the
in vivo effects of HFD exposure, increases inflammation and re-
duces ERa. PA-induced inflammation is enhanced in the
absence of ERa, and E2 pretreatment protects against PA-
induced inflammation only when ERa levels are restored. The
mechanism by which fatty acids reduce ERa involves depletion
of PGC-1a in neurons and astrocytes following PA treatment or
HFD feeding inmale, but not female, mice. Our data demonstrate
a sexually dimorphic response to an HFD or PA: an HFD sup-
presses PGC-1a only in male mice, leading to downregulation
of ERa and increased CNS inflammation, which is associated
with decrements in myocardial function.
RESULTS
Long-Term Exposure to an HFD Promotes Hypothalamic
Inflammation in Male Mice
Age-matched male and female mice were fed a chow diet or an
HFD for 16 weeks. HFD males and females gained significantly
more weight than controls (Figure 1A). Weight gain wasmatched
in male and female mice (Figure 1B). HFD feeding significantly
increased hypothalamic PA levels in males, but not in females
(Figure 1C). Consistent with previous findings (De Souza et al.,
2005; Thaler et al., 2012), HFD feeding increased proinflamma-
tory cytokines (interleukin-1b [IL-1b], tumor necrosis factor a
[TNF-a], Il6) and decreased the anti-inflammatory cytokine Il10
in the hypothalamus of male, but not female, mice (Figure 1D;
Figures S1A–S1C). Similar patterns of inflammation were found
in the hippocampus and in the cortex (Figures S1D and S1E).
No such changes were observed in females, despite similar
weight gain following the HFD (Figure 1D; Figures S1A–S1E).
Sphingolipids are important signal transduction metabolites in
immune-inflammatory responses and are antagonists of insulin
signaling (Summers, 2006). Consumption of an HFD increases
sphingolipid levels in plasma of rodents and humans (Haus
et al., 2009; Holland et al., 2013; Samad et al., 2006). We found
greater accumulation of ceramides in the hypothalamus of male
HFD mice when compared to females (Figure 1E). Glucosylcer-
amides were also significantly higher in HFD males than in
females (Figure 1E), whereas the levels of sphingomyelins were
lower in the HFD females. Collectively, these data suggest thatFigure 1. Chronic Exposure to a High-Fat Diet Promotes Inflammation
(A) Body weight at time of sacrifice. Chow male (M), n = 29; HFD M, n = 30; cho
(B) Body-weight gain following HFD exposure.
(C) Palmitic acid amount in total brain. n = 4/group.
(D) mRNA levels of inflammatory markers in hypothalamic tissue following diet e
(E) Hypothalamic sphingolipid content. n = 5/group.
(F and G) Oral glucose tolerance test (OGTT) (F) and area under the OGTT curve (G
HFD M and F, n = 5.
(H) Percent fractional shortening (%FS) following diet exposure. n = 7/group.
(I) Representative echocardiograms. LVEDd, left ventricular end-diastolic diamet
Data are presented as mean ± SEM. *p < 0.05., **p < 0.01, and ***p < 0.001. See
Cdecreased production of sphingolipids protects the hypothala-
mus of females from the proinflammatory effects of the HFD.
HFD Impairs Glucose Tolerance More in Male Than
in Female Mice
To determine the metabolic consequences of HFD-induced
inflammation, an oral glucose tolerance test (OGTT) was per-
formed on male and female mice fed chow or HFD. Previous
studies suggest female humans and rodents have improved
glucose tolerance compared to males (Macotela et al., 2009;
Yki-Ja¨rvinen, 1984). Consistent with this, chow females had
lower glucose levels than males at every time point following
the glucose gavage (Figure 1F). Although glucose homeostasis
was impaired in bothHFDmale and femalemice, therewas a sig-
nificant increase in glucose levels in HFD males when compared
to females on the same diet (Figures 1F and 1G). Importantly,
basal glucose levels and glucose clearancewere similar between
female mice exposed to the HFD and chow-fed males (neither
of which had increased markers of inflammation in the hypothal-
amus); however, HFD exposure in males significantly impaired
glucose homeostasis, and this correlated with increased
inflammation in the CNS as well as in the periphery (Figure S1F).
Notably, female mice showed higher plasma b-hydroxybutyrate
levels (Figure S1G), consistent with reports that ketone bodies
have anti-inflammatory effects (Gasior et al., 2006). Lastly,
E2 is known for its anti-inflammatory role in the CNS (Barreto
et al., 2009). E2 levels were significantly increased in females
but unchanged in males following HFD exposure (Figure S1H),
suggesting that E2 inhibits inflammation in HFD females.
Long-Term Exposure to an HFD Impairs Myocardial
Function in Male Mice
Obesity is associated with comorbidities, including cardiovascu-
lar disease (Grundy et al., 2004), and the incidence of cardio-
vascular disease is sex dependent, with an increased risk in
males when compared to premenopausal females (Czubryt
et al., 2006; Ozbey et al., 2002). Further, work published by
Purkayastha et al. demonstrates that hypothalamic inflammation
induces hypertension (Purkayastha et al., 2011). To evaluate
whether the sexual dimorphism in hypothalamic inflammation
is associated with differences in cardiovascular function, we
assessed myocardial function in male and female mice following
HFD exposure. Consistent with previous reports (Battiprolu
et al., 2012; Vo¨lkers et al., 2014), HFD feeding reduced myocar-
dial function in male mice as demonstrated by decreased
percent fractional shortening (%FS) (Figures 1H and 1I), but
not in female mice (Figures 1H and 1I). This suggests that,w female (F), n = 30; HFD F, n = 32.
xposure. Chow M and F, n = 9; HFD M, n = 10; HFD F, n = 12.
) of male and female mice fed chow or HFD for 14 weeks. ChowM and F, n = 4;
er; LVEDs, left ventricular end-systolic diameter.
also Figure S1.
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Figure 2. Chronic Exposure to a High-Fat Diet Decreases ERa
(A and B) Representative immunoblot (A) and quantification (B) of ERa in the hypothalamus. Chow M and F, n = 9; HFD M and F, n = 10.
(C) mRNA levels of Era in hypothalamic tissue. Chow M and F, n = 9; HFD M, n = 10; HFD F, n = 12.
(D and E) Representative confocal images showing ERa immunoreactivity in the ARC (D) and relative quantification (E). n = 10/group. Scale bar, 125 mm.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S2.independent of similar body weight gain following HFD expo-
sure, females are protected from the adverse effects of HFD.
Our results are supported by Louwe et al., who showed a sex-
dependent effect of HFD on cardiovascular function (Louwe
et al., 2012). These data provide the physiological relevance of
sexual dimorphisms in hypothalamic inflammation.
Long-Term Exposure to an HFD Decreases
Hypothalamic ERa Expression in Male Mice
To investigate why females are protected from the adverse
effects of the HFD, we measured ERa in hypothalamic tissue
(Figure 2), since it has previously been shown that ERa protects
against obesity-related diseases (Heine et al., 2000; Musatov
et al., 2007). We found that ERa expression was significantly
lower in the arcuate (ARC) ofmale, but not female, mice following
HFD exposure (Figure 2). Additionally, Era, and not Erb (Fig-
ure S2F), levels were significantly decreased and inflammation
increased in the hippocampus, cortex, and adipose tissue of
HFD male mice, confirming a correlation between decreased
ERa and higher tissue inflammation (Figures S2C and S2D).
Collectively, these results indicate there is a sexually dimorphic
response to HFD exposure, with greater PA, sphingolipids,
inflammation, and glucose levels in HFD males when compared
to females. These findings suggest reductions in myocardial
function in male mice are correlated with reductions in ERa
expression in the CNS.
E2 Pretreatment Protects against PA-Induced
Inflammation in Neurons through ERa
Given the increased PA in the CNS of HFD males and the asso-
ciated reductions in ERa, we addressed whether PA influences636 Cell Reports 9, 633–645, October 23, 2014 ª2014 The AuthorsERa in neurons. We exposed N43 cells (a hypothalamic cell
line expressing ERa; Figure S3A) and primary hypothalamic
neurons to PA, which significantly increased the expression of
markers of inflammation (Figures 3A and 3D) and decreased
ERa expression (Figures 3B, 3C, 3E, and 3F), supporting the hy-
pothesis that reductions in ERa are permissive for PA-induced
inflammation. To validate the sexually dimorphic response to
PA-induced inflammation, we generated primary male and
female hypothalamic neuronal cultures. PA increased inflamma-
tion and reduced ERa in male, but not female, primary neuronal
cultures (Figure 3G). Importantly, only ERa was affected; PA
treatment did not modulate Erb expression (Figure S3B). Addi-
tionally, we determined that PA exposure significantly increased
ceramide levels (Figure 3H), consistent with our findings in vivo.
To determine if these results were specific to PA, we tested the
inflammatory response to stearic and linoleic acid. Consistent
with the literature (Arruda et al., 2011), stearic acid induced
inflammation, while linoleic acid did not (Figure S3C). Impor-
tantly, ERa was significantly decreased following stearic acid,
confirming that loss of ERa is permissive for increased inflamma-
tion (Figure S3C).
E2 acts through ERa to produce an anti-inflammatory effect in
astrocytes (Barreto et al., 2009), and E2 is increased in female
mice following HFD exposure (Figure S1H). To determine
whether E2/ERa mediates a similar anti-inflammatory role in
neurons, we cotreated neuronal cells with E2 and PA. Cotreat-
ment with E2 did not decrease the PA-induced inflammation
(Figure S3D); however, ERa expression was significantly
decreased (Figures S3E and S3F). Importantly, when we pre-
treated the cells with E2 prior to PA treatment, ERa expres-
sion was not reduced (Figures 3B, 3C, 3E, and 3F) and the
PA-induced inflammation and increased ceramide levels were
significantly inhibited (Figures 3A, 3D, and 3H). To assess the
role of E2/ERa in mediating these protective effects, we trans-
fected N43 cells with an ERa-specific small interfering RNA
(siRNA) to downregulate ERa expression. Despite E2 pretreat-
ment, lack of ERa abolished the E2-induced anti-inflammatory
effect (Figure 3J), demonstrating that E2 requires ERa to
decrease PA-induced inflammation.
ERa Overexpression Significantly Protects against
PA-Induced Inflammation in Neurons
To determine whether ERa is sufficient to inhibit PA-mediated
inflammation, we infected N43 cells with an adenoviral construct
designed to overexpress ERa and treated with PA. ERa over-
expression significantly decreased the proinflammatory effect
of PA, suggesting that ERa protects against PA-induced inflam-
mation (Figure 3K).
Absence of ERa in Microglia Is Associated
with Inability of E2 to Protect against the
Proinflammatory Effects of PA
More than 50% of the brain is composed of nonneuronal cells;
microglia and astrocytes represent the most abundant cell
types. Since it has been established that an HFD activates glial
cells (Thaler et al., 2012), we evaluated the expression of ERa
in microglia. To this end, we used CX3CR1GFP/GFP mice express-
ing the GFP construct in microglial cells and performed immu-
nofluorescence with a previously validated ERa antibody
(Figure S2B) to analyze the colocalization of ERa. Consistent
with previously published reports (Saijo et al., 2011; Wu et al.,
2013), analysis of the Pearson’s coefficient confirmed ERa did
not colocalize with microglial cells in the hypothalamus (Figures
4A and 4B). To determine whether the absence of ERa in micro-
glia affects the ability of E2 to attenuate PA-induced inflamma-
tion, we treated BV2 cells, a microglial cell line lacking ERa,
with E2 and PA. Despite E2 pretreatment, E2 anti-inflammatory
activity was not observed (Figure 4C). These data confirm that
E2 requires ERa to mediate its anti-inflammatory effects.
HFD Exposure Promotes Astrogliosis in Male,
but Not Female, Mice
Chronic HFD exposure significantly activates astrocytes in ro-
dents and humans (Lee et al., 2013; Thaler et al., 2012). Analysis
of astrogliosis based on expression and staining of glial fibrillary
acidic protein (GFAP) revealed an increase in the hypothalamus
of male, but not female, mice (Figures 5A–5C). These data are
consistent with enhanced expression of markers of inflammation
in male, but not female, mice exposed to an HFD (Figure 1D).
To further elucidate the sexually dimorphic response to an
HFD, we prepared primary hypothalamic astrocytes from male
and female pups. Astrocyte activation was analyzed based
on the expression of Gfap and markers of inflammation (Il6
and Il1b). Both male and female astrocytes responded to PA
treatment by increasing Gfap, Il6, and Il1b (Figures 5D and 5E).
Interestingly, despite similar basal expression of Gfap and
inflammatory genes in male and female astrocytes, there was
significantly lower expression of these markers following PA in
female astrocytes (Figures 5D and 5E). Consistent with previousCstudies (Spence et al., 2013), ERa was expressed in these cells
(Figure S4). Increased markers of inflammation correlated with
ERa protein levels, with males showing significant reductions
in ERa following exposure to PA (Figures 5F and 5G). Pretreat-
ment of astrocytes with E2 significantly decreased markers
of inflammation in the presence of ERa (Figure 5E). These
data further confirm the sexually dimorphic response to PA,
with greater inflammation in male astrocytes correlating with a
reduction in ERa.
PGC-1a Drives ERa Loss in the Hypothalamus
of Male Mice
To address the mechanism by which HFD influences ERa within
the ARC nucleus, we focused on PGC-1a, a key transcriptional
coactivator involved in different metabolic pathways (Lin et al.,
2005). PGC-1a transcriptionally regulates ERa in vitro (Bour-
doncle et al., 2005; Tcherepanova et al., 2000); however, its
role in vivo and in the hypothalamus is unclear.
Consistent with a putative interaction between PGC-1a and
ERa, we first demonstrated that they are colocalized in the
hypothalamus (Figures 6A and 6B). To further demonstrate
that PGC-1a transcriptionally regulates ERa, we evaluated
ERa transcripts in PGC-1a/ mice. Consistent with the hypo-
thesis that exposure to an HFD reduces ERa expression in the
CNS via effects on PGC-1a, we found that Era mRNA levels
were significantly reduced inPGC-1a/mice (Figure 6C). Impor-
tantly, in ERKO mice, Pgc-1a expression was unaltered (Fig-
ure 6D), suggesting that PGC-1a regulates ERa but ERa does
not regulate PGC-1a. To confirm this finding, N43 cells were
transfected with siRNA against PGC-1a. ERamRNA and protein
levels were significantly reduced following PGC-1a downregula-
tion (Figures 6E–6G). Collectively, these results indicate that
in vitro, aswell as in vivo, PGC-1a transcriptionally regulatesERa.
HFD Exposure Decreases PGC-1a in the Hypothalamus
of Male Mice
To evaluate whether an HFD influences PGC-1a in vivo, we
analyzed PGC-1a expression following HFD exposure. The
HFD reduced PGC-1 a in the hypothalamus, hippocampus, cor-
tex, and visceral adipose tissue of male, but not female, mice
(Figure 7C; Figures S5A–S5C). Western blot and immunofluores-
cence revealed reductions in PGC-1a in the hypothalamus of
HFD male, but not female, mice (Figures 7A, 7B, 7D, and 7E).
Treatment of N43 cells, primary neurons, and primary astrocytes
with PA significantly reduced PGC-1a expression (Figures S5D–
S5F). To confirm that these effects are specific to PGC-1a and
not other nuclear transcription factors, we analyzed the expres-
sion of other nuclear transcription factors in the hypothalamus
and found they were not altered by sex or an HFD (Figure S5G).
Interestingly, PGC-1a is also decreased following stearic acid
treatment, consistent with reductions in PGC-1a being associ-
ated with inflammation (Figure S5F). Thus, our findings demon-
strate that HFD exposure and PA treatment reduce PGC-1a.
ERa Overexpression Is Sufficient to Significantly Inhibit
PA-Induced Inflammation
To determine whether reductions in PGC-1a or changes
in ERa are associated with PA-induced inflammation, weell Reports 9, 633–645, October 23, 2014 ª2014 The Authors 637
(legend on next page)
638 Cell Reports 9, 633–645, October 23, 2014 ª2014 The Authors
Figure 4. E2 Does Not Ameliorate PA-
Induced Inflammation in Microglia due to
Lack of ERa Expression
(A) Representative confocal images of ERa
immunoreactivity in the ARC of CX3CR1
GFP/GFP
male mice. Scale bar, 125 mm.
(B) Colocalization analysis of ERa and microglia in
the ARC. Pearson’s coefficient in data set volume
and in region of interest (ROI) volume: 0.0175.
Scale bar, 30 mm.
(C) BV2 cells were precultured for 1 hr with E2 and
then treated for 8 hr as indicated. Data represent
mRNA levels of inflammatory markers in BV2 cells.
Results are presented as mean ± SEM. *p < 0.05.
n = 3.overexpressed ERa in cells transfected with siRNA targeting
PGC-1a and treated with PA. PGC-1a downregulation enhanced
the proinflammatory effect of PA (Figure 7F); however, ERa
overexpression significantly inhibited PA-induced inflamma-
tion both in the presence and absence of PGC-1a (Figure 7F).
These results demonstrate that ERa overexpression is sufficient
to significantly inhibit PA-induced inflammation even in the
absence of PGC-1a.
DISCUSSION
We demonstrate a sexually dimorphic response to HFD expo-
sure, with HFD males having higher levels of PA and sphingoli-
pids in the CNS than females. Our findings further demonstrate
that males and not females have CNS and peripheral inflamma-
tion despite comparable weight gain following HFD consump-
tion. Additionally, we show that reductions in PGC-1a and ERa
facilitate inflammation. Lastly, our data demonstrate a physio-Figure 3. 17-b Estradiol, through Activation of ERa, Modulates PA-Induced Inflammation in Hy
(A–C) N43 cells were pretreated for 1 hr with E2 and then treated for 8 hr as indicated. (A) mRNA levels of Tnfa
of ERa in N43 cells following treatments. n = 3.
(D–F) Primary hypothalamic neurons were pretreated for 1 hr with E2 followed by 8 hr of the indicated trea
hypothalamic neurons following the aforementioned treatments. mRNA of Era (E) and ERa protein levels (F)
(G) mRNA levels of the indicated genes following 8 hr treatment in primary male and female hypothalamic n
(H) Ceramides content in N43 cells following pretreatment for 12 hr with E2, where indicated, and treated fo
(I) N43 cells were transfected with siRNAs, pretreated 48 hr later for 1 hr with E2, and cultured as indicated. m
treatments. The insert is a representative immunoblot of N43 cells transfected with control (UNR) siRNA or s
(J) N43 cells were infected either with AdGFP (empty vector) or with AdGFP-ERa and then treated as indica
markers following treatments. Insert shows representative immunoblots of N43 cells infectedwith the aforeme
levels 48 hr after the adenoviral exposure. n = 3.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S3.
Cell Reports 9, 633–645,logic relevance of ERa-regulated inflam-
mation to metabolic homeostasis by
demonstrating only in males a reduction
in myocardial function.
ERa functions in the CNS to regulate
food intake, glucose homeostasis, and
energy expenditure (Musatov et al.,
2007; Xu et al., 2011). HFD exposure
induces hypothalamic expression of in-
flammatory cytokines such as TNF-a,
IL-1b, and IL-6 in male mice (De Souzaet al., 2005; Thaler et al., 2012). CNS inflammation has been
associated with hypertension in male mice (Purkayastha et al.,
2011). Epidemiological studies have characterized a sexual
dimorphism in obesity-related metabolic complications, such
as cardiovascular disease, with a higher prevalence in men
and postmenopausal women than in premenopausal women
(Shi et al., 2009; Sugiyama and Agellon, 2012). Our study ex-
tends these associations by characterizing HFD-induced in-
creases in PA, sphingolipids, and inflammation and associated
reductions in myocardial function in male, but not female, mice.
Our findings demonstrate that exposure of neurons and
astrocytes to PA decreases ERa and leads to inflammation.
These data are consistent with our previous study showing
that ERa deletion induces inflammation in adipose tissues (Davis
et al., 2013). Additionally, E2 pretreatment protects against
PA-induced inflammation only if ERa is present, demonstrating
E2, which is elevated in the HFD females, requires ERa to
promote its anti-inflammatory effect. Importantly, these datapothalamic Neurons
and Il6 in N43 cells. mRNA (B) and protein (C) levels
tments. (D) mRNA levels of Tnfa and Il6 in primary
in primary neurons. n = 5.
eurons. Males, n = 5; females n = 8.
r 8 hr. n = 3.
RNA levels of inflammatory markers following the
iRNA for ERa. n = 3.
ted. Data represent mRNA levels of inflammatory
ntioned viral constructs demonstrating ERa protein
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Figure 5. HFD Exposure Promotes Astrogliosis in Male Mice
(A) mRNA levels of Gfap in the hypothalamus. n = 12/group.
(B and C) Representative confocal images (B) and quantification (C) of GFAP immunoreactivity in the ARC. n = 10/group. Scale bar, 125 mm.
(D and E) mRNA levels ofGfap (D) and Il6 and Il1b (E) in primary astrocytes. Primary astrocytes were cultured for 1 hr with E2 as indicated and then treated for 8 hr.
n = 3–4.
(F and G) Representative immunoblot (F) and quantification (g) of ERa protein levels in primary astrocytes treated as above. n = 3/group.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S4.support previous studies indicating that E2 suppresses proin-
flammatory cytokines and increases the production of anti-
inflammatory cytokines in an ERa-dependent manner in the
CNS (Spence et al., 2013; Vegeto et al., 2003).
Our finding that, in the absence of ERa, E2 does not have pro-
tective effects against PA-induced inflammation is inconsistent
with a previously proposed anti-inflammatory role for E2 acting
through ERa in microglial cells (Arevalo et al., 2010; Barreto
et al., 2009). This may be explained by the use of a microglial
cell line lacking ERa in our study. Along with other studies, we
show that microglia do not express ERa in vivo (Saijo et al.,640 Cell Reports 9, 633–645, October 23, 2014 ª2014 The Authors2011; Wu et al., 2013); therefore, we suggest that E2 does not
act through ERa in microglial cells. Saijo et al. show that ERb
in microglia has a protective role in modulating inflammation
(Saijo et al., 2011). However, we did not see changes in Erb
expression in males or females following HFD exposure; never-
theless, our data do not rule out the possibility that ERb, in
other experimental settings, modulates inflammation in micro-
glial cells.
Our data suggest that astrocytes and neurons are responsible
for the sex-related differences that we see in vivo, since
markers of inflammation are significantly increased following
Figure 6. Reductions in Hypothalamic PGC-1a Are Associated with Reductions in ERa
(A and B) IMARIS imaging of colocalization between ERa (Alexa Fluor 488) and PGC-1a (Alexa Fluor 568) reconstructed using confocal images of the hypo-
thalamus of a male mouse. Pearson’s coefficient in ROI volume = 0.3893; Pearson’s coefficient in colocalized volume = 0.1796. Scale bar, 250 mm. (B) IMARIS
imaging of the colocalization (yellow areas) between ERa and PGC-1a. Pearson’s coefficient in ROI volume = 0.4551; Pearson’s coefficient in colocalized
volume = 0.3167. Scale bar, 250 mm.
(C) mRNA levels of Era in cortex from PGC-1a/ male mice. n = 3 WT and n = 5 PGC-1a/.
(D) mRNA levels of Pgc-1a in hypothalamus from ERKO male mice. n = 6 WT and n = 5 ERKO.
(E–G) N43 cells transfected with a control siRNA (UNR) or siRNA for PGC-1a. ERa levels were measured by quantitative PCR (E) and western blot (F) 48 hr later.
(F and G) Representative immunoblot (F) and quantification (G) of ERa and PGC-1a levels of N43 cells transfected with UNR or PGC-1a siRNA.
Data are presented as mean ± SEM, and *p < 0.05.PA exposure in male neurons and astrocytes compared to
females. Importantly, ERa is also decreased in male neurons
and astrocytes following PA exposure and is partially restored
following E2 pretreatment. These data, along with other studies
(Spence et al., 2013), suggest that ERa is required in astrocytes
and neurons to modulate the fatty acid-induced inflammatory
response.
Our finding that PGC-1a regulates ERa expression in the
hypothalamus shows that this transcriptional modulation occurs
in vivo. These results extend previous reports showing thatCPGC-1a modulates ERa transcriptional activity in vitro (Bour-
doncle et al., 2005; Tcherepanova et al., 2000). We hypothesize
that PGC-1a and ERa constitute a hypothalamic signaling
system involved in the response to HFD. This appears to be spe-
cific for PGC-1aERa, since neither HFD nor sex affects other
nuclear transcription factors.
Depletion of ERa in different hypothalamic neuronal popula-
tions affects food intake, energy expenditure, and body weight
(Xu et al., 2011). We demonstrate that in the presence of fatty
acids, hypothalamic Pgc-1a expression is reduced in a sexuallyell Reports 9, 633–645, October 23, 2014 ª2014 The Authors 641
Figure 7. PGC-1a Is Decreased in the Hypothalamus of Male Mice Exposed to Chronic HFD
(A and B) Representative immunoblot (A) and quantification (B) of PGC-1a protein levels in the hypothalamus. n = 12/group.
(C) mRNA levels of PGC-1a in hypothalamus. n = 10/group.
(D and E) Representative confocal images showing PGC-1a immunoreactivity in the ARC (D) and its relative quantification (E). n = 10/group. Scale bar, 125 mm.
(F) mRNA expression of inflammatory markers from N43 cells transfected with a control siRNA (UNR) or siRNA for PGC-1a, followed by infection with AdGFP or
AdGFP-ERa and treated as indicated. n = 3.
Data are presented as mean ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S5.dimorphic manner, implicating reduced hypothalamic PGC-1a in
the development of obesity. This is consistent with reports that
PGC-1a expression is reduced in the adipose tissue of insulin-
resistant and morbidly obese individuals (Wilson-Fritch et al.,
2004) and that polymorphisms of the PGC-1a gene correlate
with increased risk of type 2 diabetes (Ek et al., 2001), findings
that further indicate a critical role for PCG-1a in modulating
metabolic function. These data, however, contradict previously
published studies of total body PGC-1a knockout mice, as well
as neuronal inactivation of PGC-1a, where reduced PGC-1a
expression protected against diet-induced obesity (Lin et al.,
2004; Ma et al., 2010). In those studies, PGC-1a deficiency led
to degenerative lesions in the brain that worsened with age (Lin
et al., 2004; Lucas et al., 2012; Ma et al., 2010). PGC-1a regu-642 Cell Reports 9, 633–645, October 23, 2014 ª2014 The Authorslates a host of genes, and in both of these published models,
PGC-1a was knocked down during development, likely provok-
ing developmental compensations that could explain the lean
phenotype. Importantly, our data demonstrate that an HFD/PA
reduces PGC-1a in the hypothalamus and that this reduction
correlates with impaired myocardial function. Further research
using inducible knockdown of PGC-1a in adult mice is required
to evaluate the role of PGC-1a in response to HFD-induced
hypothalamic inflammation independent of developmental
compensatory effects.
Loss of PGC-1a and ERa increases inflammation in the periph-
ery as well as in conditions of nutrient excess and aging (Hsiao
et al., 2013; Sczelecki et al., 2014). Here, we demonstrate
PGC-1a is a determinant of PA-induced hypothalamic
inflammation. To confirm whether loss of PGC-1a or loss of ERa
modulates the HFD/PA-induced inflammatory response, we
knocked down PGC-1a in hypothalamic neurons and simulta-
neously overexpressed ERa following PA-induced inflammation.
ERa ameliorated PA-induced inflammation, showing that it is
a critical determinant of the anti-inflammatory pathway. Never-
theless, we are aware that ERa overexpression alone does not
preclude the PA-induced inflammatory response. This suggests
that other factors are necessary to completely inhibit the PA-
induced inflammation.
In summary, HFD/PA-driven reductions in PGC-1a suppress
ERa and cause hypothalamic inflammation, which correlates
with impaired myocardial function. Our data reveal a sexually
dimorphic response to the HFD, with males having increased
CNS PA and sphingolipids when compared to females, and
this is associated with increased inflammation. The inflammatory
response to fatty acid exposure implicates the PGC-1a-ERa
pathway as the molecular basis for sexually dimorphic HFD-
induced hypothalamic inflammation. These critical insights into
the sexually dimorphic response to HFD and its impact on
myocardial function may provide a basis for future development
of sex-specific treatments for obesity and its associated meta-
bolic disorders.
EXPERIMENTAL PROCEDURES
Animals and Body Weight
Animal care and procedures were approved by the University of Texas
Southwestern Medical Center. C57BL/6 mice purchased from The Jackson
Laboratory, ERKO mice (gift from P. Chambon) (Dupont et al., 2000),
CX3CR1
GFP/GFP mice (strain B6.129P-Cx3cr1tm1Litt/J, The Jackson Labora-
tory), and PGC-1a/mice (gift from B. Spiegelman) were housed in a temper-
ature-controlled environment in groups of two to five at 22C–24C using a
12 hr light/dark cycle. Mice were fed standard phytoestrogen-free chow
(#2916, Harlan-Teklad) and exposed to a 42% HFD (#88137, Harlan-Teklad)
at 8 weeks of age. Water was provided ad libitum.
Fatty Acids Analysis
Fatty acids were quantified using pentafluorobenzoyl bromide derivatization
prior to electron capture negative ionization gas chromatography-mass spec-
trometry detection, as described previously (Quehenberger et al., 2011).
Sphingolipid Quantitation
Sphingolipids were quantified by liquid chromatography/electrospray ioniza-
tion/tandemmass spectrometry with a TSQQuantumUltra Triple Stage Quad-
rupole Mass Spectrometer (Thermo Scientific) equipped with an electrospray
ionization probe and interfaced with an Agilent 1100 HPLC (Agilent Technolo-
gies) (Holland et al., 2013).
Oral Glucose Tolerance Test
Mice were fasted for 3 hr (starting at 7 a.m.). Glucose (2.5 g/kg body weight)
was gavaged; at the indicated time points, blood samples from the tail
vein were collected. Glucose concentrations were measured using glucose
strips and a glucometer (Bayer Contour). Mice did not have access to food
throughout the experiment.
Echocardiography
Echocardiograms were performed on conscious mice using a Vevo 2100
system with a MS400C scanhead. Left ventricular end-diastolic diameter
(LVEDd) and left ventricular end-systolic diameter (LVEDs) were measured
from M-mode recordings. Fractional shortening (FS) was calculated as
(LVEDd  LVEDs)/LVEDd and expressed as a percentage. MeasurementsCwere made from 2D parasternal short-axis views in diastole at the level of
the papillary muscles (Battiprolu et al., 2012).
Cell Culture
N43 cells (Cellutions Biosystems) and BV2 cells (a gift from C.K. Glass) were
cultured in HyClone Dulbecco’s modified Eagle’s medium (Thermo Scientific)
containing 10% charcoal:dextran stripped fetal bovine serum (Gemini),
100 U/ml penicillin G sodium, 100 mg/ml streptomycin sulfate, and 100 mg/l
sodium pyruvate. Cells were grown for 24 hr before treatments with medium
containing 2% charcoal:dextran stripped fetal bovine serum. Cells were
pretreated for the indicated time with 108 M E2 (Sigma) conjugated with fatty
acid-free BSA (MP Biomedicals) and then treated for 8 hr with 108 M E2 or
100 mM PA (Matreya) conjugated with BSA alone or in combination.
RNAi in Hypothalamic Cell Cultures
Cells were cultured in six-well plates and transfected at 50% confluence with
siRNAs targeting murine ERa (Thermo Scientific) or murine PGC-1a (Thermo
Scientific) or with an unrelated control siRNA (UNR, Thermo Scientific) by
means of Lipofectamine RNAiMAX transfection reagent (Life Technologies)
according to the manufacturer’s instructions. A total of 48 hr after siRNA
transfection, cells were treated as indicated or directly lysed for protein or
RNA extraction.
Adenoviral Constructs and Infections
Adenoviruses expressing FLAG-ERa (AdERa) and GFP were constructed as
previously described (Luo et al., 2007). N43 cells were infected with the indi-
cated adenoviral constructs in 1 ml of serum-free medium. A total of 4 hr after
virus exposure, 1 ml of completely supplemented medium was added, and
48 hr later, cells were treated as indicated.
Quantitative PCR
For analysis of gene expression, mice were anesthetized and decapitated.
Tissues were stored in RNAlater (Ambion, Life Technologies) at 4C, and
24 hr later, tissues were homogenized in 1 ml of TRIzol (Ambion, Life Technol-
ogies). For analysis of gene expression in cell cultures, cells were washed
twice with cold PBS and lysed in 1 ml of TRIzol (Ambion, Life Technologies).
RNA from tissue or cells was extracted using the RNeasy Kit (QIAGEN)
according to the manufacturer’s instructions. Total RNA (1 mg) was reverse
transcribed using the SuperScript III First-Strand Synthesis System (Invitro-
gen) according to the manufacturer’s instructions. Quantitative PCR reactions
were carried out on an ABI PRISM 7700 Sequence Detection System (Applied
Biosystems). The DDCT method was used for relative quantification analysis.
Western Blot
Mouse hypothalamic tissue was dissected, immediately frozen in liquid
nitrogen after extraction, and homogenized. Protein concentration in the
supernatants was evaluated using the bicinchoninic acid technique (Pierce
Biotechnology).
N43 cells and primary neuronal cultures were collected, washed with cold
PBS and lysed using RIPA buffer supplemented with protease and phos-
phatase inhibitors (Roche Applied Science). Cell lysates were quantified as
previously described.
Proteins (30 mg) from tissues or cell lysates were separated on Criterion
TGX precast gels (Bio-Rad) and electrotransferred to membranes using the
Trans-Blot Turbo transfer system (Bio-Rad). Nonspecific binding sites were
saturated by incubating membranes for 1 hr in TBS supplemented with 5%
nonfat powdered milk (w:v in 20 mM TBS) followed by overnight incubation
with primary antibodies. Labeling was revealed with appropriate IRDye
secondary antibodies (Li-Cor) using the Odyssey Quantitative Fluorescence
Imaging Systems (Li-Cor).
Fluorescence Microscopy
Mice were anesthetized and perfused with 10% formalin. Brains were
dissected and postfixed in 10% formalin for 24 hr followed by 2 hr treatment
with 30% sucrose in PBS. Brain sections were cut at 30 mm using a Thermo
Scientific HM 450 sliding microtome (Thermo Scientific). The sections were
permeabilized in 0.01% Triton and blocked in 3% donkey serum (Jacksonell Reports 9, 633–645, October 23, 2014 ª2014 The Authors 643
Immuno Research) for 2 hr. Brain sections were incubated in the primary
antibodies overnight (ERa, Santa Cruz; GFAP, Abcam; PGC-1a, Calbiochem)
followed by the respective secondary antibodies (Alexa Fluor, Life Technolo-
gies) for 2 hr. Sections were then placed on gelatinized slides, mounted with
VECTASHIELD anti-fading medium with DAPI (Vector Laboratories), and
coverslipped. Slides were analyzed using a TCS SP2 confocal fluorescence
microscope (Leica Microsystems GmbH). Five pictures containing the ARC
region of the hypothalamus were taken from at least five mice per group,
and staining was quantified using ImageJ software (http://rsb.info.nih.gov/ij/).
Statistical Analysis
Data are presented as mean ± SEM. Statistical analyses were performed with
GraphPad Prism software (GraphPad Software) and Microsoft Office 2010
Excel. Comparisons between two conditions were made using the unpaired
two-tailed Student’s t test. A one-way ANOVA was used for comparison of
more than two groups. Scheffe’s F test was employed for post hoc analysis.
p < 0.05 was considered to be statistically significant.
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